|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Catabasis Pharmaceuticals, Inc. Promotes Michael Curtis, Ph.D., to Senior Vice President, Product Development and Regulatory Affairs
11/2/2011 8:28:47 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, a biopharmaceutical company leveraging the therapeutic potential of omega-3 fatty acids to create therapeutics for the treatment of inflammatory and metabolic diseases, today announced that Michael Curtis, Ph.D., has been promoted to senior vice president, product development and regulatory affairs. In his new position, Dr. Curtis will be responsible for chemistry, manufacturing and controls functions, toxicology, and regulatory approvals. He will continue to be responsible for leading the company’s product development strategy.
|
|
|
|
|
|
|
|
|
|
|